Nico Weigandt

Product management internship at a German orthopedic device manufacturer, May to August 2026. Following Rudolf Storz’s acquisition of Mahe Medical, I led the portfolio rationalization that merged two overlapping trauma lines into one commercial portfolio.

• Led portfolio rationalization after the Mahe Medical acquisition: analyzed five osteosynthesis implant sets across clinical performance, technical specifications, and regulatory standing, then consolidated two overlapping trauma lines into a single commercial portfolio.
• Built the scale, modify, or phase-out decision model per product family, weighing market demand, revenue margin, clinical performance, and manufacturing feasibility.
• Benchmarked biomechanical test data, material specifications, and surgical usability across five portfolios against Arthrex, Smith+Nephew, Stryker, Zimmer Biomet, and DePuy Synthes.

Research on generative AI in clinical decision support and clinician workflow; structured synthesis of peer-reviewed and industry sources, written up as a single-author working paper.

• Authored the single-author working paper “Governance Over Algorithms: Leadership, Trust, and the Future of Clinical AI Adoption”.
• Structured literature review applying an extended Technology Acceptance Model and the NASSS framework to governance, trust, and adoption dynamics of clinical AI.
• Assessed how AI tools are reshaping clinical environments, from decision support to OR documentation and clinician workflow, and what that shift asks of the teams selling into those settings.

Built the marketing plan for the School of Health Sciences: who to reach, on which channels, and with what message. Taken for credit as a graduate business internship.

• Defined audience segments and the channel mix across web, email, and social, and developed the campaign concepts aimed at growing program enrollment.
• Ran working sessions with the School of Health Sciences deans on positioning the PT and OT programs, then produced technical Q&A video content answering what prospective students actually ask.
• Translated clinical-program requirements into language non-clinical audiences act on, the same work that turns a product spec into launch messaging.

Elected to represent ~10,000 students. Functionally a multi-stakeholder role: build the case, build the coalition, close the budget.

• Stewarded an $80K annual budget covering housing, travel, food-pantry funding, and athletic events.
• Negotiated directly with the Texas A&M System Board of Regents and the Texas Higher Education Coordinating Board, with senior-stakeholder selling and consensus building.
• Won the Vice President’s Award for Outstanding Service to the University Community.

Two years leading SAAC inside an NCAA-regulated environment: strict rules, audited compliance, and real consequences for getting the process wrong.

• Led SAAC compliance education sessions for ~200 student-athletes alongside the compliance office.
• Ran formal quarterly sessions with the Athletic Director and University President and biweekly with representatives of each athletic program.
• Built reporting cadences and policy alignment in a strict, audited rules environment.

Five-year student-athlete career on full athletic scholarship. Three years at TAMIU completing a B.S. in Health Sciences (Exercise Science) in three years (Magna Cum Laude, 3.78 GPA), now continuing at St. Edward’s University through 2027 while pursuing an MBA in Digital Management.

• Competitive soccer since 2008: Rot-Weiss Essen youth academy (B-Junioren / A-Junioren Bundesliga, U17–U19) before NCAA Division II (U.S.).
• Transferred to St. Edward’s University in 2025 on continued full athletic scholarship through 2027.
• President’s Scholar Athlete Award 2025, one male and one female recipient annually.
• Sophomore of the Year nominee, 2024.
• Recovered from two ACL reconstructions, the patient experience that pointed me toward MedTech.